Age distributions of male and female subjects received JRV after PCEC or PVRV and only JRV 1) Subjects received 1 to 4 doses of chick embryo cell rabies vaccine (PCEC) in rabies endemic regions and then 1 to 5 doses of Japanese rabies vaccine (JRV) in Japan.
2) Subjects received 1 to 4 doses of purified Vero cell rabies vaccine (PVRV) in rabies endemic regions and then 1 to 5 of JRV after returned to Japan. 3) Subjects received 5 to 6 doses of JRV after returned from rabies endemic regions to Japan Table 2 Geometric mean anti-rabies antibody titers after total 3 doses of one or two kinds of rabies vaccines 1) Subjects received one or two doses of purified chick embryo cell rabies vaccine in rabies endemic regions and then one dose of Japanese rabies vaccine (JRV) in Japan.
2) Subjects received one or two doses of purified Vero cell rabies vaccine in rabies endemic regions and then one dose of JRV after returned to Japan. 3) Subjects received only JRV after returned from rabies endemic regions to Japan 4) Number of subjects whose anti-rabies antibody titers were lower than 0.5 EU/ml Table 3 Geometric mean anti-rabies antibody titers after total 5 doses of one or two kinds of rabies vaccines 1) Subjects received 1 to 4 doses of purified chick embryo cell rabies vaccine (PCEC) in rabies endemic area and then one or more doses of Japanese rabies vaccine (JRV) in Japan. Recently travelers who were bitten by possibly rabid animals in rabies endemic regions and returned to Japan have increased in number. About half of them received rabies post-exposure prophylaxis (RPEP) with one or more doses of foreign-made rabies vaccines (FRV) in the local medical institutions. FRV, however, are not available in Japan so we have to continue the RPEP with Japanese rabies vaccine (JRV). It has not been demonstrated that an anti-rabies antibody induced with JRV following Vero cell rabies vaccine (PVRV) or chick embryo cell rabies vaccine (PCEC) could be high enough to prevent clinical rabies. We examined anti-rabies antibody (ARA) titers among the subjects visited our vaccine clinic to receive RPEP and obtained results as follows: the ARA titers after a total of 5 doses of PCEC or PVRV and JRV were high enough to prevent clinical rabies as after 5 doses of JRV. However, ARA titers obtained after receiving one dose of PVRV and 2 doses of JRV seemed lower than those produced after one dose of PCEC and 2 doses of JRV or 3 doses of JRV. To accelerate antibody production, consequently, the simultaneous intradermal and subcutaneous injection method of rabies vaccine may be applied to those who were bitten in their hands or head by possibly rabid animals and received only one dose of PVRV in rabies endemic regions.
